TP53 Mutation in Colon Adenocarcinoma
Tumor SuppressorTP53 mutations occur in approximately 61% of Colon Adenocarcinoma cases. Explore survival impact, morphological differences, and co-occurring mutations below.
TP53 in Other Cancer Types
Ovarian Serous Cystadenocarcinoma 92% Uterine Carcinosarcoma 91% Esophageal Carcinoma 89% Rectum Adenocarcinoma 86% Lung Squamous Cell Carcinoma 84% Head and Neck Squamous Cell Carcinoma 74% Pancreatic Adenocarcinoma 60% Lung Adenocarcinoma 51% Brain Lower Grade Glioma 50% Bladder Urothelial Carcinoma 49% Stomach Adenocarcinoma 48% Uterine Corpus Endometrial Carcinoma 38% Breast Invasive Carcinoma 35% Sarcoma 32% Liver Hepatocellular Carcinoma 31% Glioblastoma Multiforme 28% Adrenocortical Carcinoma 20% Mesothelioma 17% Skin Cutaneous Melanoma 15% Prostate Adenocarcinoma 13% Cholangiocarcinoma 11% Cervical Squamous Cell Carcinoma 8%